secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2024-02-26T23:59:59+00:00
Accession:  0001809519-24-000020
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx extends $100M revolver to July 2025, COO Raj Beri departs with severance
-------------------------------------------------------------------------------

- Revolver maturity extended from Oct 11, 2024 to July 11, 2025; other terms unchanged.
- COO Raj Beri removed effective Feb 15, 2024; role eliminated.
- Beri to receive $1.134M cash severance (base salary + bonus) plus $375K discretionary bonus.
- Immediate vesting of 111,776 stock options at $5.94; extended exercise period for other options.
- COBRA premiums reimbursed for 12 months; Beri signed release and non-disparagement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000020/0001809519-24-000020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000020/gdrx-8xkxcafifthamendmenta.htm
  HTML page:      https://secwatch.observer/filing/0001809519-24-000020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer